BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19000229)

  • 1. Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.
    Bakchoul T; Boylan B; Sachs UJ; Bein G; Ruan C; Santoso S; Newman PJ
    Transfusion; 2009 Feb; 49(2):265-70. PubMed ID: 19000229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.
    Bakchoul T; Greinacher A; Sachs UJ; Krautwurst A; Renz H; Harb H; Bein G; Newman PJ; Santoso S
    Blood; 2013 Jul; 122(3):321-7. PubMed ID: 23645838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia.
    Bakchoul T; Kubiak S; Krautwurst A; Roderfeld M; Siebert HC; Bein G; Sachs UJ; Santoso S
    Transfusion; 2011 Nov; 51(11):2455-61. PubMed ID: 21564107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.
    Peterson JA; Kanack A; Nayak D; Bougie DW; McFarland JG; Curtis BR; Aster RH
    Transfusion; 2013 Jun; 53(6):1309-18. PubMed ID: 23003125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.
    Jackson DJ; Eastlake JL; Kumpel BM
    Clin Exp Immunol; 2014 Apr; 176(1):23-36. PubMed ID: 24261689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin α(IIb)β(3) (GPIIb/IIIa).
    Allen DL; Abrahamsson S; Murphy MF; Roberts DJ
    J Immunol Methods; 2012 Jan; 375(1-2):166-75. PubMed ID: 22036924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.
    Ghevaert C; Wilcox DA; Fang J; Armour KL; Clark MR; Ouwehand WH; Williamson LM
    J Clin Invest; 2008 Aug; 118(8):2929-38. PubMed ID: 18654666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labeled beads.
    Chong W; Metcalfe P; Mushens R; Lucas G; Ouwehand WH; Navarrete CV
    Transfusion; 2011 Jun; 51(6):1261-70. PubMed ID: 21166681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia.
    Wihadmadyatami H; Heidinger K; Röder L; Werth S; Giptner A; Hackstein H; Knorr M; Bein G; Sachs UJ; Santoso S
    Transfusion; 2015 Dec; 55(12):2920-9. PubMed ID: 26388194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
    Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
    Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads.
    Bakchoul T; Meyer O; Agaylan A; Bombard S; Bein G; Sachs UJ; Salama A; Santoso S
    Transfusion; 2007 Aug; 47(8):1363-8. PubMed ID: 17655579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new platelet alloantigen, Swi(a) , located on glycoprotein Ia identified in a family with fetal and neonatal alloimmune thrombocytopenia.
    Kroll H; Feldmann K; Zwingel C; Hoch J; Bald R; Bein G; Bayat B; Santoso S
    Transfusion; 2011 Aug; 51(8):1745-54. PubMed ID: 21332723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first reported case of neonatal alloimmune thrombocytopenia due to low-frequency human platelet antigen-6b antibodies in the United Kingdom.
    Hopkins M; Brookes J; Watson D; Wroe E; Guthrie P; Horler J; Anayattil K; Calvert A; Poles A
    Transfusion; 2021 Sep; 61(9):2788-2794. PubMed ID: 34156106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy.
    Kumpel BM; Sibley K; Jackson DJ; White G; Soothill PW
    Transfusion; 2008 Oct; 48(10):2077-86. PubMed ID: 18673340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel assay for the detection of anti-human platelet antigen antibodies (HPA-1a) based on peptide aptamer technology.
    Thibaut J; Mérieux Y; Rigal D; Gillet G
    Haematologica; 2012 May; 97(5):696-704. PubMed ID: 22133781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HPA-1a-mediated platelet phagocytosis by monocytes in vitro and its inhibition by Fc gamma receptor (FcgammaR) reactive reagents.
    Wiener E; Abeyakoon O; Benchetrit G; Lyall M; Keler T; Rodeck CH
    Eur J Haematol; 2003 Feb; 70(2):67-74. PubMed ID: 12581186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal Antibody.
    Mørtberg TV; Zhi H; Vidarsson G; Foss S; Lissenberg-Thunnissen S; Wuhrer M; Michaelsen TE; Skogen B; Stuge TB; Andersen JT; Newman PJ; Ahlen MT
    Immunohorizons; 2022 Jan; 6(1):90-103. PubMed ID: 35074850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers.
    Ghevaert C; Herbert N; Hawkins L; Grehan N; Cookson P; Garner SF; Crisp-Hihn A; Lloyd-Evans P; Evans A; Balan K; Ouwehand WH; Armour KL; Clark MR; Williamson LM
    Blood; 2013 Jul; 122(3):313-20. PubMed ID: 23656729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human platelet antigen (HPA)-specific immunoglobulin M antibodies in neonatal alloimmune thrombocytopenia can inhibit the binding of HPA-specific immunoglobulin G antibodies.
    Hopkins M; Lucas G; Calvert A; Bendukidze N; Green F; Kotecha K; Poles A
    Transfusion; 2017 May; 57(5):1267-1271. PubMed ID: 28236317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology.
    Socher I; Andrei-Selmer C; Bein G; Kroll H; Santoso S
    Transfusion; 2009 May; 49(5):943-52. PubMed ID: 19175553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.